WallStreetZenWallStreetZen

NASDAQ: TMCI
Treace Medical Concepts Inc Earnings & Revenue

TMCI past revenue growth

How has TMCI's revenue growth performed historically?
Company
26.48%
Industry
10.29%
Market
20.28%
TMCI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TMCI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TMCI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TMCI earnings and revenue history

Current Revenue
$196.0M
Current Earnings
-$54.7M
Current Profit Margin
-27.9%

TMCI Return on Equity

Current Company
-39.7%
Current Industry
7.2%
Current Market
28.2%
TMCI's Return on Equity (-39.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TMCI announces earnings.

TMCI Return on Assets

Current Company
-22.2%
Current Industry
5.8%
TMCI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TMCI Return on Capital Employed

Current Company
-25.32%
Current Industry
8.9%
TMCI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TMCI vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TMCI$196.03M-$40.79M-$54.75M+126.50%N/A
ANIK$169.26M-$68.00M-$76.83M+9.20%N/A
NNOX$10.01M-$51.41M-$61.26M+79.36%N/A
NVRO$430.75M-$62.39M-$82.59M+2.44%N/A
ZIMV$350.20M-$252.65M-$371.08M-12.76%N/A

TMCI earnings dates

Next earnings date
Aug 6, 2024

Treace Medical Concepts Earnings & Revenue FAQ

What were TMCI's earnings last quarter?

On Invalid Date, Treace Medical Concepts (NASDAQ: TMCI) reported Q1 2024 earnings per share (EPS) of -$0.30, up 30.43% year over year. Total Treace Medical Concepts earnings for the quarter were -$18.68 million. In the same quarter last year, Treace Medical Concepts's earnings per share (EPS) was -$0.23.

If you're new to stock investing, here's how to buy Treace Medical Concepts stock.

What was TMCI's earnings growth in the past year?

As of Q2 2024, Treace Medical Concepts's earnings has grown year over year. Treace Medical Concepts's earnings in the past year totalled -$54.75 million.

What is TMCI's earnings date?

Treace Medical Concepts's earnings date is Invalid Date. Add TMCI to your watchlist to be reminded of TMCI's next earnings announcement.

What was TMCI's revenue last quarter?

On Invalid Date, Treace Medical Concepts (NASDAQ: TMCI) reported Q1 2024 revenue of $51.11 million up 21.12% year over year. In the same quarter last year, Treace Medical Concepts's revenue was $42.20 million.

What was TMCI's revenue growth in the past year?

As of Q2 2024, Treace Medical Concepts's revenue has grown 26.48% year over year. This is 16.2 percentage points higher than the US Medical Devices industry revenue growth rate of 10.29%. Treace Medical Concepts's revenue in the past year totalled $196.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.